Palo Alto, CA, United States of America

Peter O'Hanley

This inventor holds 2 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Peter O'Hanley

Introduction

Peter O'Hanley is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of medical science, particularly in the development of vaccines. With a total of 2 patents, O'Hanley's work focuses on innovative solutions to combat urinary infections in mammals.

Latest Patents

O'Hanley's latest patents include a synthetic vaccine against urinary infections. This vaccine is designed to protect mammals from urinary tract infections and is prepared from synthetic peptides that are substantially equivalent to short sequences contained in HU849 pilin. The vaccine is conjugated to substantially antigenically neutral carriers or derived from a CNBrII fragment of HU849 pilin. Another significant patent is a chemically defined vaccine against urinary infections, which is prepared from purified Gal-Gal pilus proteins or fragments thereof.

Career Highlights

O'Hanley is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovations. His work has the potential to greatly impact the field of veterinary and human medicine by providing effective preventive measures against urinary infections.

Collaborations

O'Hanley has collaborated with esteemed colleagues such as Gary K Schoolnik and Stanley Falkow. These partnerships have likely contributed to the depth and breadth of his research.

Conclusion

Peter O'Hanley's contributions to vaccine development highlight his commitment to addressing critical health issues. His innovative patents reflect a dedication to improving the well-being of mammals through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…